Apellis Pharmaceuticals executive sells $33,346 in stock
James George Chopas, Vice President and Chief Accounting Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), sold 1,096 shares of the company's common stock on January 22, according to a recent ...
Apellis Pharmaceuticals chief development officer sells shares worth $39,279
In recent trading activity, Jeffrey Eisele, the Chief Development Officer of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS), has sold a portion of his holdings in the company. According to an SEC filing, ...